ArticleClinical and translational medicine2025

Topical TYK2 inhibitor ameliorates psoriasis-like dermatitis via the AKT-SP1-NGFR-AP1 pathway in keratinocytes.

Zhiqin Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.